Uncategorized - July 20, 2020
CARROLLTON, Texas, July 20, 2020 (GLOBE NEWSWIRE) — ADDvantage Technologies Group, Inc. (NASDAQ: AEY) (“ADDvantage Technologies” or the “Company”) today […]
Read More
Uncategorized - July 20, 2020
PITTSBURGH, July 20, 2020 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (Nasdaq:KRYS), a fully integrated gene therapy company driven by its […]
Read More
Uncategorized - July 20, 2020
BOSTON, July 20, 2020 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing […]
Read More
Uncategorized - July 20, 2020
NEW YORK, July 20, 2020 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, […]
Read More
Uncategorized - July 20, 2020
BOSTON, July 20, 2020 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a late-stage biopharmaceutical company aimed at developing and commercializing […]
Read More
Uncategorized - July 20, 2020
YONKERS, N.Y., July 20, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]
Read More
Uncategorized - July 20, 2020
SANTA CLARA, Calif., July 20, 2020 (GLOBE NEWSWIRE) — Applied Materials, Inc. today introduced a new technology that removes a […]
Read More
Uncategorized - July 20, 2020
China NMPA acceptance of NDA follows recent U.S. FDA approval for the treatment ofadult patients with advanced GIST who have […]
Read More
Uncategorized - July 20, 2020
EVANSVILLE, Ind., July 20, 2020 (GLOBE NEWSWIRE) —CEO COMMENTARY:SECOND QUARTER HIGHLIGHTS2: 1 Non-GAAP financial measure that Management believes is useful in […]
Read More
Uncategorized - July 20, 2020
MALVERN, Pa., July 20, 2020 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute […]
Read More